Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter Veterinary Remove Veterinary filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Withdrawn applications Remove Withdrawn applications filter Paediatric investigation plans Remove Paediatric investigation plans filter Orphan designations Remove Orphan designations filter Referrals Remove Referrals filter Direct healthcare professional communication Remove Direct healthcare professional communication filter

Product number

Decision date

From:

To:

Date of opinion

From:

To:

Referral name

Referral status

European Commission final decision (2) Apply European Commission final decision filter

Referral safety status

Yes Remove Yes filter

Referral type

Article 20 procedures Remove Article 20 procedures filter Article 31 referrals (1) Apply Article 31 referrals filter

Referral reference number

Referral decision making model

PRAC-CHMP-EC (2) Apply PRAC-CHMP-EC filter

Referral authorisation model

Centrally authorised product(s) (2) Apply Centrally authorised product(s) filter

Referral PRAC recommendation

Risk minimisation measures Remove Risk minimisation measures filter Variation Remove Variation filter Suspension (1) Apply Suspension filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Medicine type

Additional monitoring Remove Additional monitoring filter Exceptional circumstances Remove Exceptional circumstances filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

2 results

Remove all filtersRemove all filters

Categories Human Remove Human filter Veterinary Remove Veterinary filter

Medicine Withdrawn applications Remove Withdrawn applications filter Referrals Remove Referrals filter Direct healthcare professional communication Remove Direct healthcare professional communication filter Paediatric investigation plans Remove Paediatric investigation plans filter Orphan designations Remove Orphan designations filter

Medicine type Exceptional circumstances Remove Exceptional circumstances filter Additional monitoring Remove Additional monitoring filter

Referral PRAC recommendation Risk minimisation measures Remove Risk minimisation measures filter Variation Remove Variation filter

Referral safety status Yes Remove Yes filter

Referral type Article 20 procedures Remove Article 20 procedures filter

Sort by

List item

Referral: Janus kinase inhibitors (JAKi)

tofacitinib, abrocitinib, baricitinib, upadacitinib, filgotinib, associated names: Xeljanz, Cibinqo, Olumiant, Rinvoq, Jyseleca, Article 20 procedures
Status: European Commission final decision, opinion/position date: 23/01/2023, EC decision date: 10/03/2023, Last updated: 22/05/2023
List item

Referral: Lemtrada

alemtuzumab, associated names: Lemtrada, Article 20 procedures
Status: European Commission final decision, opinion/position date: 14/11/2019, EC decision date: 16/01/2020, Last updated: 04/02/2020

2 results

Referral: Janus kinase inhibitors (JAKi)

Referral: Lemtrada